Rationale for trastuzumab (Herceptin) in adjuvant breast cancer trials
Year: 2001
Type: article
Source: Seminars in Oncology
Authors: Dennis Slamon, Mark Pegram
Institution: University of California, Los Angeles
Language: English
Topic: HER2/EGFR in Cancer Research
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2168631900
